Literature DB >> 10756011

The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice.

G E Price1, A Gaszewska-Mastarlarz, D Moskophidis.   

Abstract

During influenza virus infection innate and adaptive immune defenses are activated to eliminate the virus and thereby bring about recovery from illness. Both arms of the adaptive immune system, antibody neutralization of free virus and termination of intracellular virus replication by antiviral cytotoxic T cells (CTLs), play pivotal roles in virus elimination and protection from disease. Innate cytokine responses, such as alpha/beta interferon (IFN-alpha/beta) or IFN-gamma, can have roles in determining the rate of virus replication in the initial stages of infection and in shaping the initial inflammatory and downstream adaptive immune responses. The effect of these cytokines on the replication of pneumotropic influenza A virus in the respiratory tract and in the regulation of adaptive antiviral immunity was examined after intranasal infection of mice with null mutations in receptors for IFN-alpha/beta, IFN-gamma, and both IFNs. Virus titers in the lungs of mice unable to respond to IFNs were not significantly different from congenic controls for both primary and secondary infection. Likewise the mice were comparably susceptible to X31 (H3N2) influenza virus infection. No significant disruption to the development of normal antiviral CTL or antibody responses was observed. In contrast, mice bearing the disrupted IFN-alpha/beta receptor exhibited accelerated kinetics and significantly higher levels of neutralizing antibody activity during primary or secondary heterosubtypic influenza virus infection. Thus, these observations reveal no significant contribution for IFN-controlled pathways in shaping acute or memory T-cell responses to pneumotropic influenza virus infection but do indicate some role for IFN-alpha/beta in the regulation of antibody responses. Recognizing the pivotal role of CTLs and antibody in virus clearance, it is reasonable to assume a redundancy in IFN-mediated antiviral effects in pulmonary influenza. However, IFN-alpha/beta seems to be a valid factor in determining tissue tropism and replicative rates of highly virulent influenza virus strains as reported previously by others, and this aspect is discussed here.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10756011      PMCID: PMC111913          DOI: 10.1128/jvi.74.9.3996-4003.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  55 in total

Review 1.  Virus interception of cytokine-regulated pathways.

Authors:  D V Kalvakolanu
Journal:  Trends Microbiol       Date:  1999-04       Impact factor: 17.079

2.  Mammalian type I interferon receptors consists of two subunits: IFNaR1 and IFNaR2.

Authors:  S H Kim; B Cohen; D Novick; M Rubinstein
Journal:  Gene       Date:  1997-09-01       Impact factor: 3.688

Review 3.  Pathogenicity of influenza virus.

Authors:  C Sweet; H Smith
Journal:  Microbiol Rev       Date:  1980-06

Review 4.  Cytokines as endogenous pyrogens.

Authors:  C A Dinarello
Journal:  J Infect Dis       Date:  1999-03       Impact factor: 5.226

Review 5.  Role of early cytokines, including alpha and beta interferons (IFN-alpha/beta), in innate and adaptive immune responses to viral infections.

Authors:  C A Biron
Journal:  Semin Immunol       Date:  1998-10       Impact factor: 11.130

6.  Mutant influenza viruses with a defective NS1 protein cannot block the activation of PKR in infected cells.

Authors:  E Hatada; S Saito; R Fukuda
Journal:  J Virol       Date:  1999-03       Impact factor: 5.103

7.  Antiviral defense in mice lacking both alpha/beta and gamma interferon receptors.

Authors:  M F van den Broek; U Müller; S Huang; M Aguet; R M Zinkernagel
Journal:  J Virol       Date:  1995-08       Impact factor: 5.103

8.  Cytokine profiles of bronchoalveolar lavage cells from mice with influenza pneumonia: consequences of CD4+ and CD8+ T cell depletion.

Authors:  S R Sarawar; S R Carding; W Allan; A McMickle; K Fujihashi; H Kiyono; J R McGhee; P C Doherty
Journal:  Reg Immunol       Date:  1993 May-Aug

9.  Role of interferon in the pathogenesis of virus diseases in mice as demonstrated by the use of anti-interferon serum. II. Studies with herpes simplex, Moloney sarcoma, vesicular stomatitis, Newcastle disease, and influenza viruses.

Authors:  I Gresser; M G Tovey; C Maury; M T Bandu
Journal:  J Exp Med       Date:  1976-11-02       Impact factor: 14.307

10.  Response to influenza infection in mice with a targeted disruption in the interferon gamma gene.

Authors:  M B Graham; D K Dalton; D Giltinan; V L Braciale; T A Stewart; T J Braciale
Journal:  J Exp Med       Date:  1993-11-01       Impact factor: 14.307

View more
  94 in total

1.  Critical role for perforin-, Fas/FasL-, and TNFR1-mediated cytotoxic pathways in down-regulation of antigen-specific T cells during persistent viral infection.

Authors:  Shenghua Zhou; Rong Ou; Lei Huang; Demetrius Moskophidis
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

2.  The microbial metabolite desaminotyrosine protects from influenza through type I interferon.

Authors:  Ashley L Steed; George P Christophi; Gerard E Kaiko; Lulu Sun; Victoria M Goodwin; Umang Jain; Ekaterina Esaulova; Maxim N Artyomov; David J Morales; Michael J Holtzman; Adrianus C M Boon; Deborah J Lenschow; Thaddeus S Stappenbeck
Journal:  Science       Date:  2017-08-04       Impact factor: 47.728

Review 3.  Postinfluenza bacterial pneumonia: host defenses gone awry.

Authors:  Megan N Ballinger; Theodore J Standiford
Journal:  J Interferon Cytokine Res       Date:  2010-09       Impact factor: 2.607

Review 4.  Respiratory dendritic cells: mediators of tolerance and immunity.

Authors:  Ryan A Langlois; Kevin L Legge
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

Review 5.  Toll-like receptor-independent triggering of dendritic cell maturation by viruses.

Authors:  Carolina B López; Jacob S Yount; Thomas M Moran
Journal:  J Virol       Date:  2006-04       Impact factor: 5.103

6.  Towards a quantitative understanding of the within-host dynamics of influenza A infections.

Authors:  Andreas Handel; Ira M Longini; Rustom Antia
Journal:  J R Soc Interface       Date:  2009-05-27       Impact factor: 4.118

7.  Influenza virus pathophysiology and brain invasion in mice with functional and dysfunctional Mx1 genes.

Authors:  Nicole R Hodgson; Stewart G Bohnet; Jeannine A Majde; James M Krueger
Journal:  Brain Behav Immun       Date:  2011-07-29       Impact factor: 7.217

8.  Gamma interferon-dependent protection of the mouse upper respiratory tract following parenteral immunization with a respiratory syncytial virus G protein fragment.

Authors:  Helene Plotnicky-Gilquin; Dominique Cyblat-Chanal; Jean-Pierre Aubry; Thierry Champion; Alain Beck; Thien Nguyen; Jean-Yves Bonnefoy; Nathalie Corvaïa
Journal:  J Virol       Date:  2002-10       Impact factor: 5.103

9.  Detection of mouse-adapted human influenza virus in the olfactory bulbs of mice within hours after intranasal infection.

Authors:  Jeannine A Majde; Stewart G Bohnet; Georgeann A Ellis; Lynn Churchill; Victor Leyva-Grado; Melissa Wu; Eva Szentirmai; Abdur Rehman; James M Krueger
Journal:  J Neurovirol       Date:  2007-10       Impact factor: 2.643

10.  A broadly neutralizing human monoclonal antibody is effective against H7N9.

Authors:  Kannan Tharakaraman; Vidya Subramanian; Karthik Viswanathan; Susan Sloan; Hui-Ling Yen; Dale L Barnard; Y H Connie Leung; Kristy J Szretter; Tyree J Koch; James C Delaney; Gregory J Babcock; Gerald N Wogan; Ram Sasisekharan; Zachary Shriver
Journal:  Proc Natl Acad Sci U S A       Date:  2015-08-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.